Bosulif 400 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F5RTB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,452
Award facts
- Contract value 100% obligated
- $12,451.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $12,451.85 delivery order to Amerisourcebergen Drug Corp on April 6, 2026, for Bosulif (bosutinib) 400 mg tablets, 30-count bottles, with an ultimate completion date of April 27, 2026.
The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract SPE2DX, a $999,999,999 global pharmaceutical supply vehicle running through December 2026. Place of performance is Conshohocken, Pennsylvania. Pricing is firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract SPE2DR26F5RTB?
SPE2DR26F5RTB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 6, 2026.
How much is contract SPE2DR26F5RTB worth?
The government has obligated $12,452 on SPE2DR26F5RTB.
Is contract SPE2DR26F5RTB an order under another contract?
Yes. SPE2DR26F5RTB is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5RTB competed?
The extent of competition for SPE2DR26F5RTB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award